Form DEFA14A ONCOLYTICS BIOTECH INC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailUNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
| Filed by the Registrant: | |||||||||||
| o | Definitive Proxy Statement | ||||||||||
| x | Definitive Additional Materials | ||||||||||
| o | Soliciting Material Under Rule 14a-12 | ||||||||||
| o | Confidential, for Use of the Commission Only | ||||||||||
| o | Preliminary Proxy Statement | ||||||||||
ONCOLYTICS BIOTECH INC.
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of Filing Fee (Check all boxes that apply) | |||||||||||
| x | No fee required | ||||||||||
| o | Fee paid previously with preliminary materials | ||||||||||
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | ||||||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oncolytics publishes pelareorep liver cancer immune response data
- Tribun Health Expands into Australia as CaloPix(R) 6.2.0 Is Included in the ARTG
- Lawrence A. LeBrocq Announces New Book, Victim to Victory: Triumph Over Tragedy
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
